A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies
NCT00096980
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Raptiva (efalizumab)
Sponsor
Genentech, Inc.